3i is now reportedly in exclusive talks with a consortium led by secondary investors Coller Capital and HarbourVest Partners regarding the sale of its venture portfolio, with the price tag thought to be in the region of £100m.
Shares are sold by shares were held by CapMan Buyout X Fund A and CapMan Buyout X Fund B
Advent made a takeover offer of 165 pence per share in cash, which represents a 34% premium in July
Business strategy platform will expand its product and triple its team size
Fund targets companies operating in the healthcare industry, primarily pharma, medtech and outsourced services